| Date | Title | Description |
| 04.02.2026 | Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion | NEWPORT BEACH, Calif., Feb. 4, 2026 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced that the Society for Cardiovascular Angiography & Interventions (SCAI) published an expert opinion discussing the ex... |
| 22.10.2025 | CathWorks Announces Key Events for TCT 2025 | The CathWorks FFRangio® System to be Center Stage, Featured in Multiple Scientific Sessions, Live Cases and a Primetime Academic Satellite Program
NEWPORT BEACH, Calif., Oct. 22, 2025 /PRNewswire/ -- CathWorks, a global leader in digital he... |
| 22.05.2025 | PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR | PROVISION Study, Prospective Randomized Trial Evaluating Clinical Outcomes of FFRangio Versus FFR Guidance, Demonstrates Similar MACE Rates at One Year
PARIS, May 22, 2025 /PRNewswire/ -- Today at the annual EuroPCR conference taking place ... |
| 16.05.2025 | CathWorks Announces Key Events for EuroPCR 2025 | NEWPORT BEACH, Calif. and AMSTERDAM, May 16, 2025 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming EuroPCR 2025 conference taking place ... |
| 03.01.2025 | CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial | ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across
North America, Asia, Europe and the Middle East
NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ -- CathWorks, a global leader in medical device digital health innovations, anno... |
| 28.10.2024 | PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint | PROVISION Study demonstrates significant economic and resource utilization advantages in FFRangio cohort compared to invasive wire-based FFR cohort
WASHINGTON, Oct. 28, 2024 /PRNewswire/ -- Today at the Cardiovascular Research Foundation's ... |
| 30.05.2024 | AI Can Help Detect Heart Failure Risk Early On, New Study Finds | By Aldohn Domingo
Published May 30, 2024 9:53AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
Artificial intelligence (AI) continues to substantially improve healthcare diagnosti... |
| 03.05.2024 | New Tech Uses AI to Detect Artery Blockages, Prevent Heart Attacks | Aldohn Domingo, Tech Times 03 May 2024, 01:05 am
A new artificial intelligence-powered cardiac procedure is reportedly being utilized by Florida-based AdventHealth Zephyrhills.
The new procedure, CathWorks, leverages AI to detect artery blo... |
| 26.07.2021 | CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan | KFAR-SABA, Israel and ALISO VIEJO, Calif., July 26, 2021 /PRNewswire/ -- CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ S... |
| 14.06.2021 | CathWorks : Announces Appointment of Ramin Mousavi as Chief Executive Officer and Board Member | KFAR-SABA, Israel and ALISO VIEJO, Calif., June 14, 2021 /PRNewswire/ -- CathWorks, a global leader of digital health innovation focused on helping patients with cardiovascular disease, today announced that Ramin Mousavi has been appointed ... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis
Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries.
Medical device companies, for example, raised $2.9... |
| 04.03.2019 | CathWorks Appoints Chief Financial Officer | KFAR-SABA, ISRAEL & ALISO VIEJO, Calif.–(BUSINESS WIRE)–March 4, 2019–
CathWorks announced that Mike Feher has joined CathWorks as Vice President of Finance and Chief Financial Officer. His appointment coincides with US commercializatio... |
| 25.02.2019 | CathWorks Adds Vice President of Global Marketing to Leadership Team | KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–February 25, 2019–
CathWorks announced that Ramin Mousavi has joined CathWorks as Vice President of Global Marketing & Strategy. Mr. Mousavi, an experienced cardiovascular mark... |
| 06.02.2019 | Term Sheet — Wednesday, February 6 | A PODCASTING EMPIRE
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Gimlet had raised approximately $28.5 million in venture funding from investors including WPP, Stripes Group, LionTree Part... |
| 06.02.2019 | Daily funding roundup - February 6th, 2019 | MakerSights raised $3.1M; productboard raised $10M; Jetty secured $25M; CathWorks raised $30M
MakerSights: MakerSights is a leading provider of product development software for consumer brands. MakerSights has raised $3.1 million in funding... |
| 05.02.2019 | CathWorks Closes $30M Series C Financing | CathWorks, a Kfar-Saba, Israel-based medical technology company, completed a $30m Series C financing.
The round was led by Deerfield Management.
The company intends to use the funds to accelerate its clinical and commercial activities in th... |
| 05.02.2019 |
CathWorks Collects $30M
| Aliso Viejo, California- and Kfar-Saba, Israel-based CathWorks, a developer of Fractional Flow Reserve (FFR) medical equipment used in percutaneous coronary intervention, has raised $30M in a Series C funding round, the company announced la... |
| 04.02.2019 | CathWorks Announces Completion of $30 Million Financing | Deerfield Management Leads Series C Financing
KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–February 4, 2019–
CathWorks announced the completion of a $30 million Series C financing round led by Deerfield Management.
Jim Corbet... |
| 27.12.2018 | CathWorks Names Paul Kapsner as Vice-President of Sales | Provides Experienced Commercial Leadership For CathWorks FFRangio™ U.S. Launch
KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–December 28, 2018–
CathWorks announced that Paul Kapsner has been named as Global Vice President of S... |
| 20.12.2018 | CathWorks FFRangio™ System Receives U.S. FDA Clearance | Enables non-invasive, objective functional evaluation of multi-vessel coronary artery disease
KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–December 21, 2018–
CathWorks announced today that its FFRangio™ System received United... |
| 24.09.2018 | CathWorks FFRangio™ Trial Meets Primary Endpoint and Exceeds Performance Goals | Trial Results Published in Circulation
KFAR-SABA, Israel–(BUSINESS WIRE)–September 24, 2018–
The journal Circulation published results from the CathWorks FFRangio™ FAST-FFR clinical trial in an article titled Accuracy of Fractional Flow Res... |
| 12.09.2018 | CathWorks FFRangio™ System Clinical Review Featured in TCT 2018 Program | KFAR-SABA, Israel–(BUSINESS WIRE)–September 12, 2018–
The CathWorks FFRangio™ System will be featured in a TCT Lunch Presentation Theater Program held during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Die... |
| 27.08.2018 | FAST-FFR Pivotal Trial Added to TCT 2018 Late-Breaking Clinical Trial Program | KFAR-SABA, Israel–(BUSINESS WIRE)–August 27, 2018–
CathWorks announced that the FAST-FFR pivotal trial has been added to the late-breaking clinical science program during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeti... |
| 22.08.2018 | CathWorks FFRangio™ System Files FDA 510(k) Submission | KFAR-SABA, Israel–(BUSINESS WIRE)–August 23, 2018–
CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.
The CathWorks FFRa... |
| 15.08.2018 | CathWorks FAST-FFR Trial Enrollment Completed Early | KFAR-SABA, Israel–(BUSINESS WIRE)–August 15, 2018–
CathWorks announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial is designed to evaluate efficacy of the CathWorks FFRangio™ System in terms of sensitivity and spe... |
| 11.07.2018 | CathWorks Receives CPT Code for New Wire-Free, Intraprocedural FFR Measurements to Optimize PCI Therapy Decisions | KFAR-SABA, Israel–(BUSINESS WIRE)–July 11, 2018–
CathWorks announced the approval of a new CPT code 0523T for non-invasive, 3D FFRangio™ enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions. ... |
| 03.10.2017 | Term Sheet — Tuesday, October 3 | DIRTY DEALINGS
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
But as I noted before, the numbers didn’t add up. Yesterday, Bloomberg published a story about how the company has overstated it... |
| 02.10.2017 | Cathworks Closes $15.8M Series B Financing | CathWorks Ltd., a Kfar Saba, Israel-based developer of non-invasive FFR measurements for guiding coronary interventions, completed a $15.8M Series B round of financing.
The round was led by Quark Venture and Triventures with participation f... |
